Ardelyx

$6.96
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (+0.44%) Today

+$0.10 (+1.46%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Ardelyx and other stocks, options, and ETFs commission-free!

About ARDX

Ardelyx, Inc. Common Stock, also called Ardelyx, is a biopharmaceutical company, which engages in the research, development and commercialization of medicine for the treatment of cardiorenal diseases. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet on October 17, 2007 and is headquartered in Fremont, CA. The listed name for ARDX is Ardelyx, Inc. Common Stock.

CEO

Michael G. Raab

Employees

Headquarters

Fremont, California

Founded

2007

Market Cap

619.10M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

714.47K

High Today

$6.95

Low Today

$6.80

Open Price

$6.86

Volume

390.48K

52 Week High

$8.82

52 Week Low

$4.22

Collections

Analyst Ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

ARDX Earnings

-$0.41

-$0.27

-$0.14

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 4, Pre-Market